Vinay Rajani of HDFC Securities suggests buying these stocks on July 24

From the low, Nifty recovered 470 points towards 24544 and ended the session at 24479.

trading, market, stocks
Vinay Rajani Mumbai
2 min read Last Updated : Jul 24 2024 | 6:29 AM IST

Don't want to miss the best from Business Standard?

Nifty fell for the third session in a row, with a minor fall of 0.12 per cent. During the session, Nifty hit an intraday low of 24074 and recovered sharply thereafter in the second half.

From the low, Nifty recovered 470 points towards 24544 and ended the session at 24479. Nifty managed to close above its 20 DMA, currently placed at 24311 odd levels. On the higher side 24595 and 24855 could act as a resistance, while 24074 becomes the new support for the Nifty.

Buy Strides Pharma (Rs 982): | Targets Rs 1045, 1090 | Stop-loss: Rs 950

Stock price has broken out from downward sloping trend line on the monthly chart. Price rise was accompanied by healthy volumes. Stock price has been trading above all important moving averages, indicating bullish trend on all time frames. Indicators and oscillators have turned bullish on weekly and monthly charts. Stock price has been forming higher tops and higher bottoms on the weekly and monthly charts 

Buy Deepak Fert (Rs 790): | Targets Rs 840, 885 | Stop-loss Rs 745

Stock price has surpassed the crucial resistance of double top placed at 780. For last two trading session, stock has been finding support near its 20 DMA, placed at 742. Stock price has also formed double bottom at 730 and reversed north. Indicators and oscillators have been showing strength on the weekly and monthly charts.

(Vinay Rajani, CMT, senior technical and derivative analyst, HDFC securities. Views expressed are his own.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Stock callsStocks callsBSE NSEIndian stock marketStrides Pharma ScienceStrides PharmaS&P BSE SensexNSE Nifty50 benchmark indexIndian stock exchangesDeepak Fertilisers

First Published: Jul 24 2024 | 6:29 AM IST

Next Story